Vasopressins
(JLTCWSBVQSZVLT-UHFFFAOYSA-N)
Structure
- SMILES
- NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)N.NCCCCC(C(=O)NCC(=O)N)NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(cc2)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1
- Type(s)
- Approved
- Molecular Formula:
- C92H130N28O24S4
- Molecular Weight:
- 2140.450
- Log P:
- 2.6971
- Hydrogen Bond Acceptor:
- 56
- Hydrogen Bond Donor:
- 27
- TPSA:
- 990.68
- CAS Number(s):
- 11000-17-2
Synonym(s)
1.
Vasopressins
2.
Antidiuretic Hormones
3.
beta-Hypophamine
4.
Pitressin
5.
Vasopressin
6.
Vasopressin (USP)
7.
beta Hypophamine
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Product use issue | FAERS: 3 | US FAERS | |
| 2 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 3 | Cyanosis | FAERS: 1 | US FAERS | |
| 4 | Extremity necrosis | FAERS: 1 | US FAERS | |
| 5 | Hypotension | FAERS: 1 Canada Vigilance: 1 | CTD Canada Vigilance US FAERS | |
| 6 | Nephrogenic Diabetes Insipidus | FAERS: 1 | US FAERS | |
| 7 | Supraventricular tachycardia | FAERS: 1 | US FAERS | |
| 8 | Ventricular arrhythmia | FAERS: 1 | US FAERS | |
| 9 | Bradycardia | 4945727 | CTD | |
| 10 | Hematuria | 671649 | CTD | |
| 11 | Hemorrhage | 671649 | CTD | |
| 12 | Kidney Cortex Necrosis | 465307 503094 | CTD | |
| 13 | Myocardial Ischemia | 19573579 | CTD | |
| 14 | Necrosis | 21983523 | CTD | |
| 15 | Vasoplegia | 15745296 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.